MBX Biosciences CEO Steven L. Hoerter sold shares to cover tax obligations, reflecting ongoing financial management in the pharmaceutical sector.
| Name | MBX Biosciences, Inc. |
|---|---|
| CIK | 0001776111 |
| Tickers | MBX |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 3179893100 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
MBX Biosciences CEO Steven L. Hoerter sold shares to cover tax obligations, reflecting ongoing financial management in the pharmaceutical sector.
MBX Biosciences reports share sale by director Steven Hoerter following stock vesting, reflecting ongoing equity management in the pharmaceutical sector.
MBX Biosciences, Inc. releases Q3 results, emphasizing growth in pharmaceutical preparations amid competitive industry landscape.
FMR LLC reports a 15% ownership stake in MBX Biosciences, reflecting increased interest in the pharmaceutical sector.
MBX Biosciences announces Peter Radovich as a director in a recent SEC filing, reflecting strategic changes in the pharmaceutical sector.
MBX Biosciences has granted stock options to director Peter Radovich, emphasizing its strategy to incentivize key personnel in the pharmaceutical industry.
MBX Biosciences has appointed Peter Radovich to its board of directors, signaling a strategic move in the pharmaceutical preparations sector.
238 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-128295 | 005-94623 | 261560850 | 34 | 12458 | |||
| 2026-11-12 | 4 | 4 | 0001193125-26-457015 | 6564 | ||||||
| 2026-11-10 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-007930 | 001-42272 | 261542101 | 33 | 4496 | |||
| 2026-11-10 | S-8 | S-8 | 0001193125-26-453959 | 333-299939 | 261537284 | 33 | 408938 | 1 | 1 | |
| 2026-11-09 | 10-Q | 10-Q | 0001193125-26-453583 | 001-42272 | 261535976 | 34 | 10934882 | 1 | 1 | |
| 2026-11-09 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-453553 | 001-42272 | 261535862 | 34 | 12307500 | 1 | 1 |
| 2026-11-05 | 4 | 4 | 0001193125-26-449832 | 5480 | ||||||
| 2026-11-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002806 | 005-94623 | 261526260 | 34 | 11794 | |||
| 2026-11-04 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-007744 | 001-42272 | 261521659 | 33 | 5133 | |||
| 2026-10-22 | 4 | 4 | 0001193125-26-428390 | 5516 | ||||||
| 2026-10-22 | 3 | 3 | 0001193125-26-428386 | 14692 | ||||||
| 2026-10-22 | 8-K | 8-K | 5.02,9.01 | 0001193125-26-428367 | 001-42272 | 261477264 | 34 | 160327 | 1 | 1 |
| 2026-08-27 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-369674 | 001-42272 | 261325318 | 34 | 235945 | 1 | 1 |
| 2026-08-17 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-006112 | 001-42272 | 261286525 | 33 | 5122 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-003482 | 005-94623 | 261276375 | 34 | 11486 | |||
| 2026-08-10 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001231919-26-000851 | 005-94623 | 261259787 | 34 | 36601 | |||
| 2026-08-10 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0000947871-26-000776 | 005-94623 | 261259146 | 34 | 30282 | |||
| 2026-08-06 | 10-Q | 10-Q | 0001193125-26-336849 | 001-42272 | 261246149 | 34 | 8773231 | 1 | 1 | |
| 2026-08-06 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001193125-26-336841 | 001-42272 | 261246131 | 34 | 12077146 | 1 | 1 |
| 2026-08-05 | 4 | 4 | 0001193125-26-335373 | 16719 | ||||||
| 2026-08-04 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-005629 | 001-42272 | 261239609 | 33 | 5173 | |||
| 2026-08-04 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-005628 | 001-42272 | 261239568 | 33 | 5767 | |||
| 2026-08-04 | 4 | 4 | 0001193125-26-331642 | 18681 | ||||||
| 2026-08-04 | 4 | 4 | 0001193125-26-331639 | 19829 | ||||||
| 2026-07-29 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002818 | 005-94623 | 261216880 | 34 | 10912 | |||
| 2026-07-13 | 8-K | 8-K | 5.02 | 0001193125-26-302098 | 001-42272 | 261171814 | 34 | 155091 | 1 | 1 |
| 2026-07-08 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902219-26-000214 | 005-94623 | 261161699 | 34 | 17308 | |||
| 2026-07-08 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-001474 | 005-94623 | 261161021 | 34 | 11335 | |||
| 2026-06-24 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-077301 | 005-94623 | 261115902 | 34 | 17204 | |||
| 2026-06-12 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-268477 | 001-42272 | 261084898 | 34 | 15816244 | 1 | 1 |
| 2026-06-10 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-004511 | 001-42272 | 261078944 | 33 | 9927 | |||
| 2026-06-09 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-004487 | 001-42272 | 261076634 | 33 | 9326 | |||
| 2026-06-05 | 4 | 4 | 0001193125-26-259236 | 5355 | ||||||
| 2026-06-05 | 4 | 4 | 0001193125-26-258436 | 6051 | ||||||
| 2026-06-05 | 4 | 4 | 0001193125-26-258435 | 5439 | ||||||
| 2026-06-05 | 4 | 4 | 0001193125-26-258432 | 5460 | ||||||
| 2026-06-05 | 4 | 4 | 0001193125-26-258429 | 7167 | ||||||
| 2026-06-05 | 4 | 4 | 0001193125-26-258422 | 5435 | ||||||
| 2026-06-05 | 4 | 4 | 0001193125-26-258420 | 5474 | ||||||
| 2026-06-05 | 8-K | 8-K | 5.02,5.07 | 0001193125-26-258417 | 001-42272 | 261066879 | 34 | 172450 | 1 | 1 |
| 2026-05-13 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-003576 | 001-42272 | 26973548 | 33 | 8682 | |||
| 2026-05-11 | 4 | 4 | 0001193125-26-216704 | 14825 | ||||||
| 2026-05-11 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-003490 | 001-42272 | 26962821 | 33 | 9642 | |||
| 2026-05-11 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-215676 | 001-42272 | 26960831 | 34 | 15647085 | 1 | 1 |
| 2026-05-08 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-003434 | 001-42272 | 26958413 | 33 | 5622 | |||
| 2026-05-08 | DEFA14A | DEFA14A | 0001193125-26-214615 | 001-42272 | 26958254 | 34 | 88730 | |||
| 2026-05-08 | 4 | 4 | 0001193125-26-214582 | 5498 | ||||||
| 2026-05-08 | 4 | 4 | 0001193125-26-214574 | 6585 | ||||||
| 2026-05-08 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-003419 | 001-42272 | 26957088 | 33 | 8467 | |||
| 2026-05-07 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-003370 | 001-42272 | 26952069 | 33 | 7298 | |||
| 2026-05-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-210825 | 001-42272 | 26951518 | 34 | 292998 | 1 | 1 |
| 2026-05-07 | 10-Q | 10-Q | 0001193125-26-210593 | 001-42272 | 26951164 | 34 | 7926583 | 1 | 1 | |
| 2026-05-06 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-003340 | 001-42272 | 26947975 | 33 | 4540 | |||
| 2026-05-06 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-003333 | 001-42272 | 26947875 | 33 | 4491 | |||
| 2026-05-06 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-001256 | 005-94623 | 26946867 | 34 | 11146 | |||
| 2026-05-04 | 4 | 4 | 0001193125-26-202615 | 8202 | ||||||
| 2026-05-01 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-003192 | 001-42272 | 26931791 | 33 | 6806 | |||
| 2026-04-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-001704 | 005-94623 | 26901055 | 34 | 10924 | |||
| 2026-04-22 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-003033 | 001-42272 | 26882272 | 33 | 6625 | |||
| 2026-04-22 | ARS | ARS | 0001193125-26-168545 | 001-42272 | 26881339 | 34 | 12045920 | |||
| 2026-04-22 | DEFA14A | DEFA14A | 0001193125-26-168543 | 001-42272 | 26881335 | 34 | 1191033 | |||
| 2026-04-22 | DEF 14A | DEF 14A | 0001193125-26-168536 | 001-42272 | 26881329 | 34 | 3970561 | 1 | 1 | |
| 2026-04-22 | 4/A | 4/A | 0001193125-26-168530 | 5904 | ||||||
| 2026-04-22 | 4/A | 4/A | 0001193125-26-168524 | 5833 | ||||||
| 2026-03-25 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-002613 | 001-42272 | 26791777 | 33 | 5144 | |||
| 2026-03-18 | 3 | 3 | 0001193125-26-113899 | 14583 | ||||||
| 2026-03-16 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-002351 | 001-42272 | 26756033 | 33 | 4898 | |||
| 2026-03-16 | 4 | 4 | 0001193125-26-107268 | 6093 | ||||||
| 2026-03-12 | S-3ASR | S-3ASR | 0001193125-26-104097 | 333-294237 | 26747678 | 33 | 2029304 | 1 | 1 | |
| 2026-03-12 | S-8 | S-8 | 0001193125-26-103122 | 333-294228 | 26745726 | 33 | 326821 | 1 | 1 | |
| 2026-03-12 | 10-K | 10-K | 0001193125-26-103121 | 001-42272 | 26745720 | 34 | 16466203 | 1 | 1 | |
| 2026-03-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-103118 | 001-42272 | 26745705 | 34 | 324861 | 1 | 1 |
| 2026-03-09 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-097611 | 001-42272 | 26733254 | 34 | 205087 | 1 | 1 |
| 2026-02-27 | 4 | 4 | 0001193125-26-082562 | 7916 | ||||||
| 2026-02-27 | 8-K | 8-K | 1.01,5.02,9.01 | 0001193125-26-079286 | 001-42272 | 26692675 | 34 | 2564351 | 1 | 1 |
| 2026-02-11 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000947871-26-000114 | 005-94623 | 26622557 | 34 | 31134 | |||
| 2026-02-10 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902219-26-000071 | 005-94623 | 26614306 | 34 | 17189 | |||
| 2026-02-05 | 8-K | 8-K | 8.01 | 0001193125-26-039475 | 001-42272 | 26603312 | 34 | 154879 | 1 | 1 |
| 2026-02-03 | 4 | 4 | 0001193125-26-035587 | 7043 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-035584 | 7031 | ||||||
| 2026-02-03 | 4 | 4 | 0001193125-26-035582 | 8153 | ||||||
| 2026-01-22 | 4 | 4 | 0001193125-26-018702 | 5389 | ||||||
| 2026-01-22 | 3 | 3 | 0001193125-26-018701 | 14428 | ||||||
| 2026-01-22 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-26-018700 | 001-42272 | 26549717 | 34 | 237251 | 1 | 1 |
| 2026-01-21 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-26-000690 | 005-94623 | 26545863 | 34 | 10783 | |||
| 2026-01-12 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-000259 | 001-42272 | 26526593 | 33 | 5429 | |||
| 2026-01-12 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001193125-26-009642 | 001-42272 | 26524524 | 34 | 263000 | 1 | 1 |
| 2025-12-08 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003581 | 333-291308 | 251557515 | 33 | 1754 | ||
| 2025-12-04 | CORRESP | filename1.htm | 0001193125-25-308171 | 20752 | ||||||
| 2025-11-25 | 4 | 4 | 0001193125-25-294675 | 5227 | ||||||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193125-25-282917 | 005-94623 | 251485860 | 34 | 7842 | |||
| 2025-11-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001903360-25-000005 | 005-94623 | 251474770 | 34 | 6766 | |||
| 2025-11-10 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001072613-25-000781 | 005-94623 | 251467319 | 34 | 78221 | |||
| 2025-11-07 | 4 | 4 | 0001193125-25-271118 | 5292 | ||||||
| 2025-11-06 | S-3 | S-3 | 0001193125-25-268202 | 333-291308 | 251456390 | 33 | 4717333 | 1 | 1 | |
| 2025-11-06 | 10-Q | 10-Q | 0001193125-25-268148 | 001-42272 | 251456285 | 34 | 8603993 | 1 | 1 | |
| 2025-11-06 | 8-K | 8-K | 2.02,5.02 | 0001193125-25-268146 | 001-42272 | 251456281 | 34 | 378155 | 1 | 1 |
| 2025-10-28 | 4 | 4 | 0001193125-25-252404 | 8138 | ||||||
| 2025-10-21 | 4 | 4 | 0001193125-25-245411 | 6095 | ||||||
| 2025-10-20 | 4 | 4 | 0001193125-25-243653 | 5006 | ||||||
| 2025-10-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902219-25-000364 | 005-94623 | 251376192 | 34 | 17205 | |||
| 2025-09-30 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000947871-25-000872 | 005-94623 | 251361960 | 34 | 29440 | |||
| 2025-09-30 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001876200-25-000004 | 005-94623 | 251361872 | 34 | 14830 | |||
| 2025-09-30 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001863769-25-000010 | 005-94623 | 251361320 | 34 | 50080 | |||
| 2025-09-30 | 4 | xslF345X05/form4-09302025_080948.xml | 0001231919-25-000267 | 12137 | ||||||
| 2025-09-26 | 8-K | 8-K | 1.01,9.01 | 0001193125-25-220432 | 001-42272 | 251350374 | 34 | 545510 | 1 | 1 |
| 2025-09-25 | 424B4 | 424B4 | 0001193125-25-217429 | 333-290447 | 251343714 | 33 | 1133687 | |||
| 2025-09-24 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003084 | 333-290447 | 251340143 | 33 | 1754 | ||
| 2025-09-24 | S-1MEF | S-1MEF | 0001193125-25-216138 | 333-290498 | 251340027 | 33 | 329257 | 1 | 1 | |
| 2025-09-22 | CORRESP | filename1.htm | 0001193125-25-211393 | 29552 | ||||||
| 2025-09-22 | CORRESP | filename1.htm | 0001193125-25-211387 | 20607 | ||||||
| 2025-09-22 | S-1 | S-1 | 0001193125-25-211320 | 333-290447 | 251330153 | 33 | 2042530 | 1 | 1 | |
| 2025-09-22 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-210049 | 001-42272 | 251328450 | 34 | 13576612 | 1 | 1 |
| 2025-09-04 | 8-K | 8-K | 7.01,8.01,9.01 | 0001776111-25-000007 | 001-42272 | 251291932 | 34 | 247488 | 1 | 1 |
| 2025-08-20 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001415889-25-022503 | 005-94623 | 251237794 | 34 | 36045 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-003266 | 005-94623 | 251214646 | 34 | 11326 | |||
| 2025-08-13 | UPLOAD | filename1.pdf | 0000000000-25-008532 | 377-08307 | 40406 | |||||
| 2025-08-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902219-25-000299 | 005-94623 | 251204911 | 34 | 17295 | |||
| 2025-08-08 | DRS | filename1.htm | 0000950123-25-007329 | 377-08307 | 251196812 | 33 | 1354156 | |||
| 2025-08-07 | 10-Q | 10-Q | 0000950170-25-104619 | 001-42272 | 251191847 | 34 | 8144034 | 1 | 1 | |
| 2025-08-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-104602 | 001-42272 | 251191755 | 34 | 356037 | 1 | 1 |
| 2025-06-16 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-25-086546 | 001-42272 | 251048569 | 34 | 242522 | 1 | 1 |
| 2025-06-09 | 8-K | 8-K | 7.01,9.01 | 0000950170-25-083447 | 001-42272 | 251032857 | 34 | 17089017 | 1 | 1 |
| 2025-06-06 | 4 | 4 | 0000950170-25-082773 | 5233 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-082713 | 5340 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-082703 | 5336 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-082702 | 5198 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-082701 | 5297 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-082699 | 5301 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-082698 | 5293 | ||||||
| 2025-06-06 | 8-K | 8-K | 5.02,5.07 | 0000950170-25-082697 | 001-42272 | 251028911 | 34 | 173259 | 1 | 1 |
| 2025-05-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902219-25-000189 | 005-94623 | 25933394 | 34 | 17282 | |||
| 2025-05-12 | 10-Q | 10-Q | 0000950170-25-068602 | 001-42272 | 25932713 | 34 | 7487561 | 1 | 1 | |
| 2025-05-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-068599 | 001-42272 | 25932703 | 34 | 336112 | 1 | 1 |
| 2025-04-23 | ARS | ARS | 0000950170-25-056981 | 001-42272 | 25859334 | 34 | 5818296 | |||
| 2025-04-23 | DEFA14A | DEFA14A | 0000950170-25-056980 | 001-42272 | 25859332 | 34 | 1198058 | |||
| 2025-04-23 | DEF 14A | DEF 14A | 0000950170-25-056978 | 001-42272 | 25859330 | 34 | 3994923 | 1 | 1 | |
| 2025-04-10 | 4 | 4 | 0000950170-25-052685 | 4864 | ||||||
| 2025-04-09 | 4 | 4 | 0000950170-25-052313 | 5400 | ||||||
| 2025-04-07 | 3 | 3 | 0000950170-25-051379 | 14010 | ||||||
| 2025-04-07 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-25-051371 | 001-42272 | 25816429 | 34 | 239987 | 1 | 1 |
| 2025-03-17 | S-8 | S-8 | 0000950170-25-039843 | 333-285846 | 25742510 | 33 | 371852 | 1 | 1 | |
| 2025-03-17 | 10-K | 10-K | 0000950170-25-039838 | 001-42272 | 25742452 | 34 | 28981983 | 1 | 1 | |
| 2025-03-17 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-039837 | 001-42272 | 25742441 | 34 | 352936 | 1 | 1 |
| 2025-02-19 | 4 | xslF345X05/ownership.xml | 0000947871-25-000200 | 13347 | ||||||
| 2025-02-19 | 4 | xslF345X05/ownership.xml | 0000947871-25-000199 | 17199 | ||||||
| 2025-02-05 | 4 | 4 | 0000950170-25-014499 | 5393 | ||||||
| 2025-02-05 | 4 | 4 | 0000950170-25-014497 | 5381 | ||||||
| 2025-02-05 | 4 | 4 | 0000950170-25-014494 | 8455 | ||||||
| 2025-01-07 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0000950170-25-002555 | 001-42272 | 25513467 | 34 | 234990 | 1 | 1 |
| 2024-11-08 | SC 13G | SEC SCHEDULE 13G | 0000902219-24-000474 | 005-94623 | 241438644 | 34 | 36172 | |||
| 2024-11-07 | 10-Q | 10-Q | 0000950170-24-122840 | 001-42272 | 241433359 | 34 | 8339827 | 1 | 1 | |
| 2024-11-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-122824 | 001-42272 | 241433300 | 34 | 299408 | 1 | 1 |
| 2024-11-01 | SC 13G | SC 13G | 0001193125-24-249976 | 005-94623 | 241420165 | 34 | 36888 | |||
| 2024-09-23 | SC 13D | SC 13D | 0001104659-24-102144 | 005-94623 | 241317230 | 34 | 150972 | |||
| 2024-09-23 | SC 13D | NEW ENTERPRISE ASSOCIATES 17, L.P. -- MBX BIOSCIENCES, INC. 13D | 0001072613-24-000721 | 005-94623 | 241317226 | 34 | 469024 | |||
| 2024-09-23 | SC 13D | SCHEDULE 13D | 0000947871-24-000767 | 005-94623 | 241316606 | 34 | 117463 | |||
| 2024-09-23 | SC 13G | deeptrack-mbx091324.htm | 0001172661-24-004091 | 005-94623 | 241316251 | 34 | 103334 | |||
| 2024-09-23 | SC 13D | SC 13D | 0001193125-24-223402 | 005-94623 | 241315132 | 34 | 417219 | |||
| 2024-09-20 | SC 13G | SEC SCHEDULE 13G | 0001903360-24-000002 | 005-94623 | 241312024 | 34 | 18734 | |||
| 2024-09-17 | 4 | 4 | 0000950170-24-107558 | 13018 | ||||||
| 2024-09-17 | 4 | 4 | 0000950170-24-107556 | 12882 | ||||||
| 2024-09-17 | 4 | 4 | 0000950170-24-107554 | 12980 | ||||||
| 2024-09-17 | 4 | 4 | 0000950170-24-107552 | 12978 | ||||||
| 2024-09-17 | 4 | 4 | 0000950170-24-107549 | 13014 | ||||||
| 2024-09-17 | 4 | 4 | 0000950170-24-107547 | 12987 | ||||||
| 2024-09-17 | 4 | 4 | 0000950170-24-107544 | 13014 | ||||||
| 2024-09-17 | 4 | 4 | 0000950170-24-107542 | 12972 | ||||||
| 2024-09-17 | 4 | 4 | 0000950170-24-107540 | 12894 | ||||||
| 2024-09-17 | 4 | 4 | 0000950170-24-107538 | 22674 | ||||||
| 2024-09-17 | 4 | 4 | 0000950170-24-107537 | 15995 | ||||||
| 2024-09-17 | 4 | 4 | 0000950170-24-107536 | 16449 | ||||||
| 2024-09-17 | 4 | 4 | 0000950170-24-107532 | 8833 | ||||||
| 2024-09-17 | 4 | 4 | 0000950170-24-107530 | 11807 | ||||||
| 2024-09-17 | 4 | 4 | 0000950170-24-107527 | 17477 | ||||||
| 2024-09-17 | 4 | 4 | 0000950170-24-107525 | 9505 | ||||||
| 2024-09-17 | 4 | 4 | 0000950170-24-107524 | 18979 | ||||||
| 2024-09-17 | 4 | 4 | 0000950170-24-107489 | 10770 | ||||||
| 2024-09-16 | 8-K | 8-K | 5.03,9.01 | 0001193125-24-219621 | 001-42272 | 241301300 | 34 | 173574 | ||
| 2024-09-13 | 4 | 4 | 0000950170-24-106478 | 5736 | ||||||
| 2024-09-13 | 4 | 4 | 0000950170-24-106476 | 5235 | ||||||
| 2024-09-13 | 4 | 4 | 0000950170-24-106467 | 5334 | ||||||
| 2024-09-13 | 4 | 4 | 0000950170-24-106457 | 5346 | ||||||
| 2024-09-13 | 4 | 4 | 0000950170-24-106456 | 5226 | ||||||
| 2024-09-13 | 4 | 4 | 0000950170-24-106441 | 5324 | ||||||
| 2024-09-13 | 4 | 4 | 0000950170-24-106440 | 5274 | ||||||
| 2024-09-13 | 4 | 4 | 0000950170-24-106439 | 5239 | ||||||
| 2024-09-13 | 4 | 4 | 0000950170-24-106436 | 5136 | ||||||
| 2024-09-13 | 4 | 4 | 0000950170-24-106431 | 5231 | ||||||
| 2024-09-13 | S-8 | S-8 | 0001193125-24-218888 | 333-282106 | 241298092 | 33 | 98004 | |||
| 2024-09-13 | 424B5 | 424B5 | 0001193125-24-218860 | 333-281764 | 241297857 | 33 | 5001710 | |||
| 2024-09-12 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-09-12 16:00:00 | 9999999995-24-002818 | 333-281764 | 241296349 | 33 | 1709 | ||
| 2024-09-12 | 3 | 3 | 0000950170-24-106132 | 6252 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106129 | 34196 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106127 | 34238 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106122 | 27278 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106121 | 34118 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106116 | 34242 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106111 | 34211 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106106 | 34238 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106102 | 34202 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106099 | 34204 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106096 | 21845 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106094 | 34106 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106090 | 20409 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106088 | 9655 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106087 | 18790 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106081 | 19825 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106080 | 18076 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106078 | 21942 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106075 | 19483 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106072 | 12974 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106070 | 18299 | ||||||
| 2024-09-12 | 3 | 3 | 0000950170-24-106067 | 20829 | ||||||
| 2024-09-12 | S-1MEF | S-1MEF | 0001193125-24-218157 | 333-282075 | 241295949 | 33 | 61319 | |||
| 2024-09-12 | CERT | 8A_Cert_MBX.pdf | 0001354457-24-000674 | 001-42272 | 241294353 | 34 | 761632 | |||
| 2024-09-10 | 8-A12B | 8-A12B | 0001193125-24-216643 | 001-42272 | 241290391 | 34 | 14829 | |||
| 2024-09-10 | CORRESP | filename1.htm | 0001193125-24-216604 | 9011 | ||||||
| 2024-09-10 | CORRESP | filename1.htm | 0001193125-24-216599 | 7025 | ||||||
| 2024-09-09 | S-1/A | S-1/A | 0001193125-24-215436 | 333-281764 | 241285721 | 33 | 5508957 | |||
| 2024-08-30 | CORRESP | filename1.htm | 0001193125-24-211226 | 16512 | ||||||
| 2024-08-30 | S-1/A | S-1/A | 0001193125-24-211217 | 333-281764 | 241271077 | 33 | 5873830 | |||
| 2024-08-30 | UPLOAD | filename1.pdf | 0000000000-24-009916 | 377-07147 | 43496 | |||||
| 2024-08-26 | CORRESP | filename1.htm | 0001193125-24-207272 | 111789 | ||||||
| 2024-08-23 | CORRESP | filename1.htm | 0001193125-24-206234 | 13333 | ||||||
| 2024-08-23 | S-1 | S-1 | 0001193125-24-206227 | 333-281764 | 241236876 | 33 | 7121724 | |||
| 2024-07-22 | UPLOAD | filename1.pdf | 0000000000-24-008281 | 377-07147 | 42372 | |||||
| 2024-07-11 | DRSLTR | filename1.htm | 0000950123-24-006483 | 20332 | ||||||
| 2024-07-11 | DRS/A | filename1.htm | 0000950123-24-006482 | 377-07147 | 241112644 | 33 | 5817493 | |||
| 2024-05-07 | UPLOAD | filename1.pdf | 0000000000-24-005188 | 377-07147 | 47380 | |||||
| 2024-04-26 | DRSLTR | filename1.htm | 0000950123-24-003578 | 51109 | ||||||
| 2024-04-26 | DRS/A | filename1.htm | 0000950123-24-003577 | 377-07147 | 24883276 | 33 | 4227439 | |||
| 2024-04-17 | UPLOAD | filename1.pdf | 0000000000-24-004189 | 377-07147 | 62436 | |||||
| 2024-03-22 | DRS | filename1.htm | 0000950123-24-002979 | 377-07147 | 24776119 | 33 | 5281599 | |||
| 2022-11-18 | D | xslFormDX01/primary_doc.xml | 06b | 0001776111-22-000001 | 021-465364 | 221402325 | 33 | 12728 | ||
| 2020-07-27 | D | xslFormDX01/primary_doc.xml | 06b | 0001776111-20-000001 | 021-371833 | 201049071 | 33 | 7625 | ||
| 2019-05-10 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001776111-19-000002 | 021-339344 | 19816087 | 33 | 7690 | ||
| 2019-05-10 | D | xslFormDX01/primary_doc.xml | 06b | 0001776111-19-000001 | 021-339344 | 19814276 | 33 | 7600 |
One latest value per concept from companyfacts (172 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 49.66M | 2026-11-05 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 237.33M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 4,257.17 | 2026-11-05 | S-8 | 2026-11-10 | 0001193125-26-453959 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 4,257.17 | 2026-11-05 | S-8 | 2026-11-10 | 0001193125-26-453959 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 48.93M | 2026-11-05 | S-8 | 2026-11-10 | 0001193125-26-453959 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-11-05 | S-8 | 2026-11-10 | 0001193125-26-453959 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 6.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 1.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | AccruedEmployeeBenefitsCurrent | Accrued Employee Benefits, Current | USD | 5.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 17.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 952,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -1.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 822.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 27.55M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 5.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | Assets | Assets | USD | 500.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 492.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 1.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 322.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 100.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 220.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 320.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 15,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 161.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 481.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 161.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 86.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 49.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 49.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 6,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -125.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 20.34M | 2024-08-30 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 | |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 276,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 68.07M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 15.65M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 35.46M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 221,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 14.12M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 1.38M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 1.09M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 67.79M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 400,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | Depreciation | Depreciation | USD | 283,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -2.58 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -2.58 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.259 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.003 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | -0.027 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.086 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 64.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -69,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0000950170-25-039838 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 53.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -87.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestAccrued | Income Tax Examination, Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 | |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | IncomeTaxPaidStateAndLocalAfterRefundReceived | IncomeTaxPaidStateAndLocalAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 22.51M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -18.26M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 24,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 151,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -246,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 2.33M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 7.45M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 3.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 5.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | 2.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001193125-26-336849 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 2.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | 11.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | InterestReceivableCurrent | Interest Receivable, Current | USD | 3.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | Liabilities | Liabilities | USD | 27.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 500.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 25.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 319.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 189.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -25.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -77.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -123.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -123.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 134.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -134.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 500,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 787,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 2.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 200,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 2.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 559,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 2.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 247,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | -2.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax | USD | 54,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -2.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | OtherResearchAndDevelopmentExpense | Other Research and Development Expense | USD | 6.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 536,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 237.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 2.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 11.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 688.80M | 2026-02-04 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 63.50M | 2024-01-01 | 2024-09-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-268148 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 215.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 7.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 254,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -123.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 5.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 5.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | RedeemableNoncontrollingInterestEquityPreferredCarryingAmount | Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0000950170-25-039838 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 81.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 205,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -347.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | SecurityDeposit | Security Deposit | USD | 42,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | SegmentReportingOtherItemAmount | SegmentReportingOtherItemAmount | USD | 41.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 39.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.9 | 2024-01-01 | 2024-06-30 | 2025 | Q2 | 10-Q | 2025-08-07 | 0000950170-25-104619 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 1.178 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 1.043 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.046 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.037 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 116.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 2.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 11.23 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 28.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 51 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 585,593 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 1.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 37.52 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 184.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 5.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 22.34 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 184.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 5.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 22.34 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 6.90M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 8.1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 39.07 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 21.91 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 44.66 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 472.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.083 | 2024-09-06 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 869,222 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 254,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 85.02M | 2026-01-01 | 2026-03-31 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001193125-26-336849 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 1.43M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | StockRepurchasedDuringPeriodValue | Stock Repurchased During Period, Value | USD | 19,000 | 2025-01-01 | 2025-03-31 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 0 | 2024-09-16 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2024-09-16 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 6.73M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 2.25M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 141,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 26.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001193125-26-103121 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 47.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 47.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453583 |